CASP1 and metabolic dysfunction-associated steatotic liver disease: In the HFD-induced NAFLD model, Casp-1/11−/− mice had higher body weight and more severe hepatic steatosis, with a higher diversity of intestinal bacteria but a lower abundance of lactobacilli in the gut microbiota, even under a normal diet [84].